Filing Details
BIOGEN INC. (NASDAQ:BIIB) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 29, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:BIIB
BIOGEN INC. (BIIB) Files Quarterly Report for Q0
Filing Details BIOGEN INC. (NASDAQ:BIIB) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 29, 2026. The Healthcare company reported Q0…
Market Context
BIOGEN INC.'s stock currently trades at $209.23 with a market capitalization of $25.3B.
The 10-Q provides BIOGEN INC.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for BIOGEN INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View BIIB Stock Page
Frequently Asked Questions
Where can I read BIIB's SEC filings?
Browse all filings on our BIIB SEC filings page.
What types of SEC filings does BIOGEN INC. file?
Public companies like BIOGEN INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
